CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
212.31%
Change (1 year)
Categories
Market capitalization of CymaBay Therapeutics (CBAY)
Market cap: $3.72 Billion
As of May 2024 CymaBay Therapeutics has a market cap of $3.72 Billion. This makes CymaBay Therapeutics the world's 3179th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CymaBay Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.72 B | 39.19% |
| 2023 | $2.67 B | 404.49% |
| 2022 | $0.53 B | 85.53% |
| 2021 | $0.28 B | -27.62% |
| 2020 | $0.39 B | 192.88% |
| 2019 | $0.13 B | -71.15% |
| 2018 | $0.46 B | 15.95% |
| 2017 | $0.40 B | 894.86% |
| 2016 | $40.56 M | 2.37% |
| 2015 | $39.62 M | -72.57% |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of CymaBay Therapeutics was reported to be:
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $163.65 B | 4,289.67% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $91.01 B | 2,341.23% | 🇺🇸 USA |
 Xencor XNCR | $1.37 B | -63.09% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.62 B | -29.60% | 🇺🇸 USA |